Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | FASTA | Matteo Ramazzotti | ||||||
GSE203432 |
Exploring the microbiota pecularity in stool and biopsies of Eosinophilic Granulomatosis with Polyangiitis (EGPA) patients
|
45 | Matteo Ramazzotti | Jun 29, 2022 | ||||
GSE206765 |
Comparing the microbiota composition between Cocaine addicted and Healthy subjects and the corresponding shift caused by rTMS treatment.
|
159 | Matteo Ramazzotti | May 31, 2023 | ||||
GSE206807 |
Evaluating the gut microbiota shifts caused by two diets based on ancient grains
|
74 | Matteo Ramazzotti | Aug 24, 2022 | ||||
GSE222755 |
Survey of microbiota composition differences between obese subjects before and after Lactiplantibacillus plantarum probiotic treatment
|
68 | Matteo Ramazzotti | May 03, 2023 | ||||
GSE223002 |
Evaluating the microbiota shift caused by Msc knock-out in wild type and DSS-induced colitis mice
|
16 | Matteo Ramazzotti | Jan 06, 2024 | ||||
GSE225848 |
Aging-related changes of facial skin microbiome in healthy women.
|
15 | Matteo Ramazzotti | Feb 24, 2023 | ||||
GSE228424 |
Comparing the adrenal gland microbiota composition between healthy subjects and patient with adrenal corticoma
|
35 | Matteo Ramazzotti | Sep 20, 2023 | ||||
GSE162844 |
16S V3-V4 -based microbial profiling of matched healthy and inflamed ileal mucosa from patients affected by Crohn’s disease
|
20 |
|
Matteo Ramazzotti | Nov 22, 2021 | |||
GSE163366 |
Analysis of the microbiota composition of colorectal mucosa tissues and adjacent healthy tissues of 40 patients affected by colorectal cancer.
|
80 |
|
Matteo Ramazzotti | Dec 17, 2020 | |||
GSE181070 |
16S V3-V4 -based microbial profiling of duodenal mucosa samples obtained by esophagogastroduodenoscopy from patients affected by potential celiac disease and celiac disease
|
27 |
|
Matteo Ramazzotti | Oct 19, 2022 | |||
GSE198329 |
16S V3-V4 -based microbial profiling of matched healthy and inflamed ileal mucosa from patients affected by Crohn’s disease (set 2)
|
26 |
|
Matteo Ramazzotti | Jul 21, 2022 | |||
GSE200486 |
16S V3-V4 -based microbial profiling of stool, skin and saliva samples of patients affected by systemic sclerosis (SSc)
|
78 |
|
Matteo Ramazzotti | Dec 28, 2023 | |||
GSE202396 |
Microbiota exploring in CAVD: the potential fil rouge from aortic valve calcification to infiltrating bacteria
|
20 |
|
Matteo Ramazzotti | Feb 08, 2023 | |||
GSE212891 |
Analysis of microbiota composition within breast tumor and healthy breast tissues in males and females
|
41 |
|
Matteo Ramazzotti | Jun 14, 2023 | |||
GSE216589 |
Comparing the microbiota composition between HPV positive and negative patients with CRC
|
22 |
|
Matteo Ramazzotti | Oct 15, 2023 | |||
GSE240646 |
First exploration of the altered microbial gut-lung axis in the pathogenesis of human refractory chronic cough
|
39 |
|
Matteo Ramazzotti | Apr 17, 2024 | |||
GSE253108 |
DSS-colitis induced in young age accelerates the onset of cognitive defects in Tg2576 mice, a model of Alzheimer disease
|
44 |
|
Matteo Ramazzotti | May 29, 2024 | |||
GSE254843 |
Experimental tests strongly challenge the evidence of a healthy human blood microbiome
|
15 | Matteo Ramazzotti | Mar 01, 2024 | ||||
GSE261579 |
Deciphering the gut microbiota of very early systemic sclerosis (VEDOSS): the first taxonomic and functional characterization
|
65 |
|
Matteo Ramazzotti | Nov 27, 2024 | |||
GSE278875 |
Host Genetics and Gut Microbiota Influence Lipid Metabolism and Inflammation: Potential implications for ALS Pathophysiology in SOD1 G93A Mice
|
101 |
|
Matteo Ramazzotti | Nov 13, 2024 |